VanEck Pharmaceutical ETF
PPH
PPH
46 hedge funds and large institutions have $121M invested in VanEck Pharmaceutical ETF in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
99% less call options, than puts
Call options by funds: $361K | Put options by funds: $24.3M
Holders
46
Holding in Top 10
–
Calls
$361K
Puts
$24.3M
Top Buyers
| 1 | +$31.1M | |
| 2 | +$1.83M | |
| 3 | +$1.59M | |
| 4 |
IMC Chicago
Chicago,
Illinois
|
+$1.35M |
| 5 |
DI
DFPG Investments
Sandy,
Utah
|
+$703K |
Top Sellers
| 1 | -$4.97M | |
| 2 | -$2.76M | |
| 3 | -$1.37M | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$807K |
| 5 |
OPS
Orion Portfolio Solutions
Omaha,
Nebraska
|
-$595K |